Dimeric TAT Peptide for Endosomal Escape and Cytosolic Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protein transduction strategies face inefficiencies in delivering molecules into cells due to endosomal entrapment, often resulting in low cytosolic levels and adverse effects on cell viability, with existing methods being suboptimal and cytotoxic.
Innovation Solution
A dimeric cell-penetrating peptide (dTAT) compound is developed, formed by a disulfide bond between two TAT peptides, which facilitates endosomal escape and efficient delivery of molecules into the cytosol without affecting cell viability or proliferation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If membrane-destabilizing agents are used to increase endosomal escape ability, then delivery efficiency is improved, but cell viability is adversely affected due to plasma membrane lysis
Solution Approach 1:
The patent modifies the physical and chemical parameters of the cell-penetrating peptide by introducing a specific amphipathic alpha-helical structure with defined hydrophobic and hydrophilic faces. This structural parameter change enables the peptide to interact selectively with endosomal membranes while maintaining compatibility with plasma membranes, thereby improving delivery efficiency without compromising cell viability.
Solution Approach 2:
The peptide is designed with non-uniform charge distribution and amphipathic properties, creating local quality differences where one face is hydrophobic and the other is hydrophilic. This local quality differentiation allows selective interaction with endosomal membranes while avoiding harmful effects on plasma membranes, resolving the contradiction between delivery efficiency and cell viability.
2Quantity of substance
If PTD-proteins utilize the endocytic pathway for cellular entry, then cellular uptake is achieved, but protein reaches the cytosol at low levels due to endosomal entrapment
Solution Approach 1:
The patent introduces a specifically designed cell-penetrating peptide as an intermediary that facilitates the transition of proteins from endosomal entrapment to cytosolic release. This peptide mediator binds to the protein of interest and actively promotes endosomal escape, thereby increasing the quantity of protein that successfully reaches the cytosol while utilizing the endocytic pathway for initial cellular entry.
3Productivity
If hydrophobic membrane-active peptides are used to improve protein delivery, then endosomal escape is enhanced, but delivery efficiency remains low due to peptide hydrophobicity issues
Solution Approach 1:
The patent systematically optimizes the physical and chemical parameters of the peptide including charge distribution, hydrophobicity-hydrophilicity balance, and structural conformation. By adjusting these parameters to create an amphipathic alpha-helical structure with specific properties, the patent achieves effective endosomal escape while maintaining reasonable peptide design and simplifying the overall delivery system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
dTAT achieves high efficiency in delivering proteins and small molecules into cells, with minimal toxicity and the ability to deliver multiple molecules simultaneously, maintaining cell health and allowing for repeated delivery without compromising the endocytic route.
Implementation Method 1
A dimeric cell-penetrating peptide (dTAT) compound is developed, formed by a disulfide bond between two TAT peptides
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present disclosure provides methods and compositions related to the cytosolic delivery of proteins and cell-impermeable small molecules into live cells using an endosomolytic dimer of cell-penetrating peptide TAT.